Viewing nowCombinationSeltepozigen 5/160 mg
Valsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Celltrion Pharmaceutical Co., Ltd.

MFDS item code 201401227 · Approved 2014.03.17 · Insurance code 693901250
Treatment of essential hypertension not controlled by monotherapy
This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled with either amlodipine or valsartan alone. This means that when satisfactory blood pressure control is difficult with single-drug therapy, this medicine can help effectively manage blood pressure.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended that the dose of each individual component (amlodipine or valsartan) be adjusted. However, if blood pressure is not controlled with monotherapy using either component, a direct switch to this medicine may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher). However, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Caution should be exercised when increasing the dose.
Use of this medicine is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.
This medication should be discontinued immediately if pregnancy is confirmed, as it can cause serious harm or death to the fetus and newborn if taken during the second or third trimester of pregnancy. Patients with allergic reactions to the active ingredients or similar substances, pregnant women, those with severe kidney dysfunction, severe liver dysfunction, and specific kidney disease should not take this medication. Patients with low sodium or body fluid should manage their condition before taking this medication and should carefully monitor blood pressure and status during use. Those with high potassium levels or taking potassium supplements, potassium-sparing diuretics, etc., should frequently check potassium levels while on this medication. Patients with renal artery stenosis or those who have received a kidney transplant should closely monitor kidney function while on this medication. If symptoms of angioedema occur, the medication should be stopped immediately and should not be resumed, and careful evaluation before use is required for patients with severe heart failure or recent myocardial infarction. Patients with acute myocardial infarction should be cautious as symptoms of angina or myocardial infarction may worsen with this medication. Patients with aortic stenosis, mitral stenosis, or obstructive hypertrophic cardiomyopathy require special caution when using this medication. This medication can increase the risk of hypotension, hyperkalemia, and worsening renal function when used with other angiotensin receptor blockers, ACE inhibitors, or aliskiren, so it is advisable to avoid such combinations or closely monitor blood pressure and renal function. Dizziness and fatigue may occur during treatment, so caution is advised when driving or operating machinery. This medication can cause various adverse reactions, with common symptoms including headache, swelling, fatigue, and dizziness. Severe allergic reactions, liver dysfunction, and cardiac arrhythmias may occur, so if any unusual symptoms arise, consult a healthcare professional immediately. This medication may interact with other drugs, so it is essential to inform healthcare professionals of any ongoing treatments, particularly if taking potassium supplements, diuretics, NSAIDs, simvastatin, or CYP3A4 inhibitors or inducers. Breastfeeding women are advised to avoid taking this medication, and its use is not recommended for pediatric patients under 18 years of age due to insufficient evidence of safety and efficacy. Overdose can lead to hypotension, dizziness, and cardiac rhythm disturbances; hence, caution should be exercised to avoid exceeding the recommended dose, and immediate medical attention is required in case of overdose.
Pharyngitis, Influenza, Hypersensitivity, Visual impairment, Anxiety, Headache, Dizziness, Drowsiness, Orthostatic dizziness, Paresthesia, Vertigo, Tinnitus, Tachycardia, Palpitations, Syncope, Orthostatic hypotension, Hypotension, Cough, Pain in the throat and larynx, Diarrhea, Nausea, Abdominal pain, Constipation, Thirst, Rash, Erythema, Sweating, Itching, Joint swelling, Back pain, Arthritis, Muscle spasms, Lethargy, Frequency of urination, Polyuria, Erectile dysfunction, Edema, Localized edema, Facial edema, Peripheral edema, Fatigue, Flushing, Weakness, Facial flushing, Decreased hemoglobin, Decreased hematocrit, Neutropenia, Thrombocytopenia, Includes hypersensitivity with serum sickness, Increased serum potassium, Vasculitis, Elevated liver function tests, Angioedema, Myalgia, Renal failure, Kidney damage, Increased serum creatinine, Insomnia, Decreased libido, Pharyngitis, Rhinitis, Sinusitis, Upper respiratory tract infection, Viral infection, Diplopia, Thrombocytopenic purpura, Leukopenia, Allergic reaction, Hyperglycemia, Insomnia, Mood changes, Tremor, Sensory impairment, Dysgeusia, Peripheral neuropathy, Hypertonicity of muscles, Arrhythmia, Bradycardia, Atrial fibrillation, Ventricular tachycardia, Myocardial infarction, Vasculitis, Shortness of breath, Rhinitis, Vomiting, Dyspepsia, Pancreatitis, Gastritis, Gingival hyperplasia, Hepatitis, Jaundice, Alopecia, Purpura, Skin depigmentation, Photosensitivity reaction, Angioedema, Urticaria, Erythema multiforme, Stevens-Johnson syndrome, Myalgia, Voiding dysfunction, Nocturia, Gynecomastia, Pain, Apathy, Chest pain, Weight loss, Weight gain, Increased liver enzymes, Confusional state, Exfoliative dermatitis, Stevenson-Johnson syndrome, Photosensitivity reaction, Toxic epidermal necrolysis, Dizziness, Hypotension, Reflex tachycardia, Systemic hypotension, Shock, Non-cardiogenic pulmonary edema
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container as it may be sensitive to air or moisture. It is recommended to maintain a storage temperature between 1 degree to 30 degrees Celsius to safely preserve the medication's efficacy.
Dark yellow oblong film-coated tablet
28 tablets (14 tablets/Alu-Alu x 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Celltrion Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.